Autoantibody against N(ε)-(carboxymethyl) lysine: An advanced glycation end product of the maillard reaction

Diabetes

Volumn 48, Issue 9, 1999, Pages 1842-1849

  Shibayama, Rie ^b   Araki, None ^a   Nagai, Ryoji ^a   Horinchi, Seikoh ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NISSHIN SEIFUN GROUP INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AUTOANTIBODY; BOVINE SERUM ALBUMIN; EPITOPE; LENS PROTEIN; LYSINE DERIVATIVE; CRYSTALLIN; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADOLESCENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE DURATION; GLYCATION; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; WISTAR RAT;

ANIMALS; AUTOANTIBODIES; CRYSTALLINS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MAILLARD REACTION; MALE; RATS; RATS, WISTAR;

EID: 0032587740     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1842     Document Type: Article

References (53)

1. Maillard LC: Action des acides amines sur les sucres: formation des melanoidines par voie methodique. C R Acad Sci (Paris) 154:66-68, 1912
2. Finot PA: Nutritional and metabolic aspects of protein modification during food processing. In Modification of Proteins. Feeny RE, Whitaker JR, Eds. Washington, DC, American Chemical Society, 1982, p. 91-124
3. Sell DR, Monnier VM: End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 85:380-384, 1990
4. Ienaga K, Nakamura K, Hochi T, Nakazawa Y, Fukunaga Y, Kakita H, Nakano K: Crosslines, fluorophores in the AGE-related cross-linked proteins. Contrib Neptirol 112:42-51, 1995
5. Konishi Y, Hayase F, Kato H: Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci Biotech Biochem 58:1953-1955, 1994
6. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, Tatemichi N, Takei Y: Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280, 1997
7. ε-carboxymethyllysine as a degradation product of fructoserysine in glycated protein. J Biol Chem 261:4889-4894, 1986
8. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM: Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 263:3758-3764, 1989
9. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S: Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214, 1992
10. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S: Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 208:53-56, 1996
11. Makino H, Shikata K, Hironaka K, Kushiro M, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 48:517-526, 1995
12. Yamada K, MiyaharaY, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tuchida H, Mimura N, Araki N, Horiuchi S: Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 42:354-361, 1994
13. Imai N, Nishi S, Suzuki Y, Karasawa R, Ueno M, Shimada H, Kawashima S, Nakamura T, Miyakawa Y, Araki N, Horiuchi S, Gejyo F, Arakawa M: Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy. Nephron 76:153-160, 1997
14. Hammes H-P Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT: Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 75:325-338, 1996
15. Murata T, Nagai R, Ishibashi T, Inomata H, Ikeda K, Horiuchi S: The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40:764-769, 1997
16. Kume S, Takeya M, Mon T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K: Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667, 1995
17. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R: Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am JPathol 143:1649-1656, 1993
18. Meng J, Sakata N, Takebayashi S, Asano T, Furata T, Araki N, Horiuchi S: Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 45: 1037-1043, 1996
19. Miyata T, Oda O, Inagi R, lida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T: β-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
20. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci U S A 93:2353-2358, 1996
21. Kimura T, Takamatsu J, Araki N, Goto M, Kondo A, Miyakawa T, Horiuchi S: Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease? Neuroreport 6:866-868, 1995
22. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A: Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci U S A 91:4766-4770, 1994
23. Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G: Advanced Maillard reaction end products are associated with Alzheimer's disease pathology. Proc Natl Acad Sci U S A 91: 5710-5714, 1994
24. ε(carboxymethyl) lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 108:797-802, 1997
25. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunonistochemical detection of advanced glycosylation endproducts in the peritoneum and its possible pathophysiological role in CAPD. Kidney Intbl: 182-186, 1997
26. Horiuehi S, Araki N, Morino Y: Immunochemical approach to characterize advanced glycation end products of the Maillaed reaction. J Biol Chem 266: 7328-7332, 1991
27. ε-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083, 1996
28. Takata K, Horiuchi S, Araki N, Shiga M, Saitoh M, Morino Y: Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldeyde-modified proteins. J Biol Chem 263:14819-14825, 1988
29. ε-(carboxymethyl)lysine formation from amadori product. Biochem Biophys Res Commun 234:167-172, 1997
30. ε-(carboxymethyl)hyclroxylysine in human ski collagen. Biochemistry 30:1205-1210, 1991
31. ε-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872-10878, 1995
32. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
33. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R: Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 258:651-353, 1992
34. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H: Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438, 1993
35. Blumenthal HT, Hirata Y, Owens CT, Berns AW: A histo- and immunologic analysis of the small vessel lesion of diabetes in the human and in the rabbit. In Small Blood Vessel Involvement in Diabetes Mellitus. Siperstein MD, Wolwell AR, Meyer K, Eds. Washington, DC, American Institute of Biological Sciences, 1964, p. 279-287
36. Mauer SM, Michael AF, Fish AJ, Brown DM: Spontaneous immunoglobulin and complement deposition in glomeruli of diabetic rats. Lab Invest 27:488-494, 1972
37. Brownlee M, Cerami A, Vlassara H: Adavanced glycosylation end products in tissue and the biochemical basis of diabetic complications. JV Eng J Med 318: 1315-1321, 1988
38. Witztum JL, Steinbrecher UP, Kesaniemi YA, Fisher M: Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. Proc Natt Acad Sci USA 81:3204-3208, 1984
39. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86: 1372-1376, 1989
40. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
41. Yla-Herttuala S, Palinsky W, Butler SW, Picard S, Steinberg D, Witztum JL: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL Arterioscler Thromb 14:32-40, 1994
42. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL ApoE-deficient mice are a model lipoprotein oxidation in atherogenesis. Arteriosder Thromb 14:605-616, 1994
43. Palinski W, Miller E, Witztum JL: Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Prof Natl Acad Sci USA 92:821-825, 1995
44. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL: Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arteriosder Thromb Vasc Biol 15:1569-1576, 1995
45. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL: Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotin E-deficient mice. J Clin Invest 98:800-814, 1996
46. Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J Clin Invest 98:815-825, 1996
47. Palinski W, Koschjnsky T, Butler SW, Miller E, Vlassara H, Cerami A, Witztum JL: Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vase Biol 15:571-582, 1995
48. Njoroge FG, Femandes AA, Monnier VM: Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole. J Biol Chem 263:10646-10652, 1988
49. Horiuchi S, Shiga M, Araki N, Takata K, Saitoh M, Morino Y: Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation. J Biol Chem 263:18821-18826, 1988
50. Baydanoff S, Konova E, Ivanova N: Determination of anti-AGE antibodies in human serum. Glycoconjugate J 13:335-339, 1996
51. Nakayama H, Taneda S, Kuwajima S, Aoki S, Kuroda Y, Misawa K, Nakagawa S: Production and characterization of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 162:740-745, 1989
52. Dorrian CA, Cathcart S, Clausen D, Shapiro D, Dominiczak MH: Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069-1079
53. ε-(Carboxymethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-570, 1997